Strategic Collaboration Paraza Pharma is a Montreal-based drug discovery company with a focus on accelerating lead identification through development, presenting a compelling partner for contract research, collaboration-friendly opportunities, and joint development programs with larger biologics and small-molecule players.

Expert Talent Led by veterans from Merck, Pfizer, Wyeth, Boehringer-Ingelheim, AstraZeneca and Schering-Plough, the team combines high-level drug discovery expertise with established industry networks, enabling rapid scoping of projects and potential advisory or executive-level engagement for clients.

Funding Signals Reported revenue of 25 to 50 million USD and a growing reputation evidenced by recent leadership hires and partnerships, suggesting potential capacity for scaled CRO-style services, milestone-based engagements, and co-development deals.

Strategic Partnerships History of collaboration with Mila, a premier deep learning research center, and active participation in major chemistry conferences, indicating openness to AI-enabled drug discovery solutions and sponsorship opportunities that align with industry trends.

Market Positioning Compared to mid-to-large CROs, Paraza is a specialized, agile option with a strong science-led brand, which can be pitched for targeted discovery projects, early lead optimization programs, and flexible engagement models for biotech and pharma clients seeking faster timelines.